bioTheranostics Revenue and Competitors
Estimated Revenue & Valuation
- bioTheranostics's estimated annual revenue is currently $27.1M per year.
- bioTheranostics's estimated revenue per employee is $193,750
- bioTheranostics's total funding is $32M.
Employee Data
- bioTheranostics has 140 Employees.
- bioTheranostics grew their employee count by -3% last year.
bioTheranostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Consultant | Reveal Email/Phone |
2 | VP Laboratory Operations | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | VP Market Access | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Commercial Officer | Reveal Email/Phone |
7 | Director Quality | Reveal Email/Phone |
8 | Chief Scientific Officer | Reveal Email/Phone |
9 | Sr. Director Biostatistics | Reveal Email/Phone |
10 | Regional Director | Reveal Email/Phone |
bioTheranostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is bioTheranostics?
AviaraDx, Inc. is a molecular cancer profiling company that is focused on developing and commercializing molecular diagnostic technologies with proven clinical utility. The Company leverages its technological leadership position in the analysis of cancer biopsies and proprietary bioinformatic methodologies to discover and validate novel diagnostic, prognostic and predictive biomarkers for better cancer treatment. Diagnostic laboratories in the US and Europe have licensed the Company’s molecular cancer identification (MCID) and breast cancer profiling (BCP) technologies to develop and commercialize certain laboratory tests.
keywords:N/A
$32M
Total Funding
140
Number of Employees
$27.1M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
bioTheranostics News
... chief medical consultant for breast oncology at Hologic subsidiary Biotheranostics. BCI has shown it can help inform these decisions,...
... Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics.
The American Society of Clinical Oncology (ASCO) updated its guidelines to recommend use of Biotheranostics Inc.' Breast Cancer Index (BCI)...
bioTheranostics, a San Diego, CA-based developer of molecular diagnostics for cancer, closed a $32m private equity financing. The round was led by MVM Life Science Partners, with participation from Canepa Advanced Healthcare Fund and HealthQuest Capital. As a result of the financing, bioTherano ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $41.6M | 140 | 33% | N/A |
#2 | $22.3M | 140 | 3% | N/A |
#3 | $41.6M | 140 | 15% | N/A |
#4 | $39.4M | 141 | 4% | N/A |
#5 | $3.5M | 141 | 25% | N/A |